| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Departments of
*
Surgery and
Molecular Genetics and Microbiology, University of Florida College of Medicine, Gainesville, FL 32610;
Stanford Genome Technology Center, Palo Alto, CA 94305; and
Zyomyx, Hayward, CA 94545
Thoracoabdominal aortic aneurysm repair, with its requisite intraoperative mesenteric ischemia-reperfusion, often results in the development of systemic inflammatory response syndrome, multiorgan dysfunction syndrome (MODS), and death. In the present study, an adverse clinical outcome following thoracoabdominal aortic aneurysm repair was identified by blood leukocyte genomic and plasma proteomic responses. Time-dependent changes in the expression of 146 genes from blood leukocytes were observed (p < 0.001). Expression of 138 genes (p < 0.001) and the concentration of seven plasma proteins discriminated between patients who developed MODS and those who did not, and many of these differences were evident even before surgery. These findings suggest that changes in blood leukocyte gene expression and plasma protein concentrations can illuminate pathophysiological processes that are subsequently associated with the clinical sequelae of systemic inflammatory response syndrome and MODS. These changes in gene expression and plasma protein concentrations are often observed before surgery, consistent with either a genetic predisposition or pre-existing inflammatory state.
This article has been cited by other articles:
|
|
 |
|
  A. Pachot, M.-A. Cazalis, F. Venet, F. Turrel, C. Faudot, N. Voirin, J. Diasparra, N. Bourgoin, F. Poitevin, B. Mougin, et al. Decreased Expression of the Fractalkine Receptor CX3CR1 on Circulating Monocytes as New Feature of Sepsis-Induced Immunosuppression J. Immunol., May 1, 2008; 180(9): 6421 - 6429. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kuivaniemi, C. D. Platsoucas, and M. D. Tilson III Aortic Aneurysms: An Immune Disease With a Strong Genetic Component Circulation, January 15, 2008; 117(2): 242 - 252. [Full Text] [PDF]
|
|
|
|
 |
|
 L. L. Moldawer Opening the Window on Genome-wide Expression Analyses in Sepsis Am. J. Respir. Crit. Care Med., October 1, 2007; 176(7): 631 - 632. [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Shanbhag, A. M. Kaufman, K. Hayata, and H. E. Rubash Assessing Osteolysis with Use of High-Throughput Protein Chips J. Bone Joint Surg. Am., May 1, 2007; 89(5): 1081 - 1089. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Matt, T. Carrel, M. White, I. Lefkovits, and J. Van Eyk Proteomics in cardiovascular surgery J. Thorac. Cardiovasc. Surg., January 1, 2007; 133(1): 210 - 214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Liu, W.-J. Qian, M. A. Gritsenko, W. Xiao, L. L. Moldawer, A. Kaushal, M. E. Monroe, S. M. Varnum, R. J. Moore, S. O. Purvine, et al. High Dynamic Range Characterization of the Trauma Patient Plasma Proteome Mol. Cell. Proteomics, October 1, 2006; 5(10): 1899 - 1913. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Tabibiazar, R. A. Wagner, A. Deng, P. S. Tsao, and T. Quertermous Proteomic profiles of serum inflammatory markers accurately predict atherosclerosis in mice Physiol Genomics, April 13, 2006; 25(2): 194 - 202. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. V. Podgoreanu and D. A. Schwinn New Paradigms in Cardiovascular Medicine: Emerging Technologies and Practices: Perioperative Genomics J. Am. Coll. Cardiol., December 6, 2005; 46(11): 1965 - 1977. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Tomic, S. Russwurm, E. Moller, R.A. Claus, M. Blaess, F. Brunkhorst, M. Bruegel, K. Bode, F. Bloos, J. Wippermann, et al. Transcriptomic and Proteomic Patterns of Systemic Inflammation in On-Pump and Off-Pump Coronary Artery Bypass Grafting Circulation, November 8, 2005; 112(19): 2912 - 2920. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
